Equity Details
Price & Market Data
Price: $7.12
Daily Change: +$0.12 / 1.69%
Daily Range: $6.88 - $7.52
Market Cap: $276,402,784
Daily Volume: 1,239,193
Performance Metrics
1 Week: -54.79%
1 Month: -48.74%
3 Months: -34.20%
6 Months: 3.04%
1 Year: -19.27%
YTD: -30.74%
About Entrada Therapeutics, Inc. (TRDA)
Discover key statistics for Entrada Therapeutics, Inc. (TRDA). The stock is trading at 7.12, reflecting a daily change of +$0.12 / 1.69%. Its market capitalization is 276,402,784. Review its performance history, including 1-week and 1-year trends.
Company Details
Employees: 152
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.